Blog

By Alex Perálvarez-Marín Introduction: In Wang et al. we have studied and described an intermediate step of the molecular mechanism of sugar transport thanks to the possibility to run several MD simulation replicates in the 100 ns range using a single GPU-based desktop running ACEMD. Our solvated membrane protein system embedded in the lipid bilayer

Continue Reading →

What has been achieved in Molecular Dynamics and Acellera contribution. Acellera celebrates its 10th anniversary. A decade focusing on molecular dynamics (MD) and dedicated to improve this technique as a strong partner of biophysical approaches. Objectively, molecular dynamics is the only technique allowing to study conformational changes and interaction at atomistic level, to quantify binding

Continue Reading →

By Franck Chevalier Introduction: Molecular recognition is rarely a two-body protein-ligand problem, as it often involves the dynamic interplay of multiple molecules that together control the binding process. Myo-inositol monophosphatase (IMPase), a drug target for bipolar disorder, depends on 3 Mg2+ ions as cofactor for its catalytic activity. Although the crystallographic pose of the pre-catalytic

Continue Reading →

By Franck Chevalier Introduction on kinetics Quest for new drug discovery usually involves a clear understanding of ligand binding to its receptor. Free binding energy helps to rank compounds and allows to select those based on their target affinity. Drug discovery programs focused on optimization of target affinity as a proxy of in-vivo efficacy Within

Continue Reading →

By Franck Chevalier Meet Acellera during Spring & Summer’16 Conferences. Fragment Based Drug Discovery (FBDD), Markov state model, free energy methods, drug discovery by high throughput molecular dynamics (HTMD); these are few of the topics developed during the events we will join within the next weeks. Learn more about ACEMD, HTMD and our last released Metrocubo workstation and server.

Continue Reading →